lisa klow K McCarthy (@lisa.s.mccarthy.9) • Facebook GLOW Peptide Journey: 3-Week Progress
Description
Rx Only 5 mL Product does not contain plasma/albumin Single-dose only Takeda 6521302 IU: LOT: EXP: ADVATE [Antihemophilic Factor (Recombinant)] For Intravenous Administration Only Rx Only ADVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Product does not contain plasma/albumin 6521293 Takeda IU: LOT: EXP: ADVATE [Antihemophilic Factor (Recombinant)] NDC 0944-3046-10 Single-dose only For Intravenous Administration Only Rx Only Lyophilized powder for reconstitution ADVATE and diluent preassembled in BAXJECT III system Product does not contain plasma/albumin ACTUAL POTENCY 5 mL Takeda ADVATE [Antihemophilic Factor (Recombinant)] NDC 0944-3046-11 For Intravenous Administration Only ADVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion
DAPI staining was used to confirm the nuclear localization of Hb, and regions of interest (ROIs) for DAPI-negative nucleolar regions were manually selected to quantify Hb signal intensity specifically within these regions
Free radical scavenging behavior of folic acid: Evidence for possible antioxidant activity
Still, the varying doses succeeded in boosting levels of IGF-1, which reflects the level of GH, by 88%
If the peptide world is so sure it works, run the trial